Moors & Cabot, Inc. Abiomed Inc Transaction History

Moors & Cabot, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$310.19 - $376.2 $23.5 Million - $28.5 Million	75,874 New	75,874 $1.5 Million
Q4 2019 Jan 28, 2020	SELL	$159.31 - $223.54 $290,740 - $407,960	-1,825 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$175.89 - $279.23 $17,589 - $27,923	100 Added 5.8%	1,825 $325,000
Q2 2019 Jul 18, 2019	SELL	$250.96 - $284.94 $4,517 - $5,128	-18 Reduced 1.03%	1,725 $450,000
Q1 2019 May 06, 2019	SELL	$276.39 - $362.25 $481,747 - $631,401	-1,743 Reduced 50.0%	1,743 $497,000
Q1 2019 May 01, 2019	BUY	$276.39 - $362.25 $486,722 - $637,922	1,761 Added 102.09%	3,486 $994,000
Q4 2018 Feb 13, 2019	SELL	$281.08 - $444.25 $42,162 - $66,637	-150 Reduced 8.0%	1,725 $561,000
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $17,726 - $22,487	50 Added 2.74%	1,875 $842,000
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $11,122 - $17,848	40 Added 2.24%	1,825 $746,000
Q1 2018 May 18, 2018	BUY	$192.49 - $295.85 $343,594 - $528,092	1,785 New	1,785 $519,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.